• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. Sep 1996; 74(6): 925–929.
PMCID: PMC2074725

Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.

Abstract

The prognostic value of preoperative serum concentrations of carcinoembryonic antigen (CEA), CA 242, tissue polypeptide antigen (TPA), specific tissue polypeptide antigen (TPS) and human chorionic gonadotrophin beta (hCG beta) in 251 patients with colorectal cancer (39 Dukes' A, 98 Dukes' B, 56 Dukes' C and 58 Dukes' D) was investigated. When using the cut-off levels recommended for diagnostic purposes, there was a significantly longer overall survival in patients with low tumour marker levels compared with patients with elevated serum levels for all the investigated markers. In Dukes' stage B, C and D CA 242 emerged as a significant predictor of survival, whereas TPA, TPS and hCG beta showed a value only in Dukes' D. Unfortunately, no marker provided prognostic information in Dukes' A. In multivariate analysis, entering the tumour markers as continuous variables, Dukes' stage was the strongest prognostic factor, followed by CA 242. TPS, hCG beta and localisation of the tumour were also independent prognostic factors, whereas age, gender, CEA and TPA were not.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (850K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Alfthan H, Haglund C, Roberts P, Stenman UH. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. Cancer Res. 1992 Sep 1;52(17):4628–4633. [PubMed]
  • Bogenschütz O, Brümmendorf T, Staab HJ, Anderer FA, Kieninger G. Prognostic value of preoperative serum CEA level compared to clinical staging. IV. Histological grading and tumor type in colorectal and gastric cancer. J Surg Oncol. 1986 Jul;32(3):165–173. [PubMed]
  • Brümmendorf T, Anderer FA, Staab HJ, Hornung A, Stumpf E, Kieninger G. Prognostic value of preoperative serum CEA level compared to clinical staging: III. An approach to scoring of prognostic factors in colorectal cancer. J Surg Oncol. 1985 Apr;28(4):263–269. [PubMed]
  • Carpelan-Holmström M, Haglund C, Kuusela P, Järvinen H, Roberts PJ. Preoperative serum levels of CEA and CA 242 in colorectal cancer. Br J Cancer. 1995 Apr;71(4):868–872. [PMC free article] [PubMed]
  • Deans GT, Parks TG, Rowlands BJ, Spence RA. Prognostic factors in colorectal cancer. Br J Surg. 1992 Jul;79(7):608–613. [PubMed]
  • Dhar P, Moore T, Zamcheck N, Kupchik HZ. Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA. 1972 Jul 3;221(1):31–35. [PubMed]
  • Filella X, Molina R, Grau JJ, Piqué JM, Garcia-Valdecasas JC, Astudillo E, Biete A, Bordas JM, Novell A, Campo E, et al. Prognostic value of CA 19.9 levels in colorectal cancer. Ann Surg. 1992 Jul;216(1):55–59. [PMC free article] [PubMed]
  • Goslin R, Steele G, Jr, Macintyre J, Mayer R, Sugarbaker P, Cleghorn K, Wilson R, Zamcheck N. The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Ann Surg. 1980 Dec;192(6):747–751. [PMC free article] [PubMed]
  • Hall NR, Finan PJ, Stephenson BM, Purves DA, Cooper EH. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer. 1994 Sep;70(3):549–553. [PMC free article] [PubMed]
  • Hohenberger P, Schlag PM, Gerneth T, Herfarth C. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Ann Surg. 1994 Feb;219(2):135–143. [PMC free article] [PubMed]
  • Jass JR, Atkin WS, Cuzick J, Bussey HJ, Morson BC, Northover JM, Todd IP. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology. 1986 May;10(5):437–459. [PubMed]
  • Kuusela P, Haglund C, Roberts PJ. Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer. 1991 Apr;63(4):636–640. [PMC free article] [PubMed]
  • Lindmark G, Bergström R, Påhlman L, Glimelius B. The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer. Br J Cancer. 1995 May;71(5):1090–1094. [PMC free article] [PubMed]
  • Moertel CG, O'Fallon JR, Go VL, O'Connell MJ, Thynne GS. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer. 1986 Aug 1;58(3):603–610. [PubMed]
  • Nilsson O, Johansson C, Glimelius B, Persson B, Nørgaard-Pedersen B, Andrén-Sandberg A, Lindholm L. Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer. 1992 Feb;65(2):215–221. [PMC free article] [PubMed]
  • Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg. 1994 Jul;60(7):528–532. [PubMed]
  • Ståhle E, Glimelius B, Bergström R, Påhlman L. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. I. Prediction of tumour stage. Eur J Surg Oncol. 1988 Aug;14(4):277–286. [PubMed]
  • Ståhle E, Glimelius B, Bergström R, Påhlman L. Preoperative serum markers in carcinoma of the rectum and rectosigmoid. II. Prediction of prognosis. Eur J Surg Oncol. 1988 Aug;14(4):287–296. [PubMed]
  • Steele G, Jr, Ellenberg S, Ramming K, O'Connell M, Moertel C, Lessner H, Bruckner H, Horton J, Schein P, Zamcheck N, et al. CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg. 1982 Aug;196(2):162–169. [PMC free article] [PubMed]
  • Turnbull RB, Jr, Kyle K, Watson FR, Spratt J. Cancer of the colon: the influence of the no-touch isolation technic on survival rates. Ann Surg. 1967 Sep;166(3):420–427. [PMC free article] [PubMed]
  • Wanebo HJ, Rao B, Pinsky CM, Hoffman RG, Stearns M, Schwartz MK, Oettgen HF. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med. 1978 Aug 31;299(9):448–451. [PubMed]
  • Wang JY, Tang R, Chiang JM. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum. 1994 Mar;37(3):272–277. [PubMed]
  • Wiggers T, Arends JW, Volovics A. Regression analysis of prognostic factors in colorectal cancer after curative resections. Dis Colon Rectum. 1988 Jan;31(1):33–41. [PubMed]
  • Wolmark N, Fisher B, Wieand HS, Henry RS, Lerner H, Legault-Poisson S, Deckers PJ, Dimitrov N, Gordon PH, Jochimsen P, et al. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. Ann Surg. 1984 Apr;199(4):375–382. [PMC free article] [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...